scispace - formally typeset
J

Janet J. Maguire

Researcher at University of Cambridge

Publications -  148
Citations -  7273

Janet J. Maguire is an academic researcher from University of Cambridge. The author has contributed to research in topics: Receptor & Endothelin receptor. The author has an hindex of 44, co-authored 133 publications receiving 6267 citations. Previous affiliations of Janet J. Maguire include British Heart Foundation & University College London.

Papers
More filters
Journal ArticleDOI

Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis

TL;DR: It is concluded that VSMC apoptosis is 'silent' in normal arteries, which have a large capacity to withstand cell loss, and that SM22α-hDTR Apoe−/− mice may represent an important new model to test agents proposed to stabilize atherosclerotic plaques.
Journal ArticleDOI

Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration

TL;DR: It is concluded that VSMC apoptosis is sufficient to accelerate Atherosclerosis, promote plaque calcification and medial degeneration, prevent expansive remodeling, and promote stenosis in atherosclerosis.
Journal ArticleDOI

[Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart. Vasoactive Mechanisms and Inotropic Action in Disease

TL;DR: It is demonstrated that the 3 principal forms of apelin have comparable potency and efficacy in human cardiovascular tissues for the first time.
Journal ArticleDOI

Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1

TL;DR: The distribution of receptors for human urotensin‐II (U‐II) in human and rat CNS and peripheral tissues is determined and a potential role for U‐II in human physiology is suggested.
Journal ArticleDOI

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors

Stephen P.H. Alexander, +154 more
TL;DR: The Concise Guide to PHARMACOLOGY 2021/22 as mentioned in this paper provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands.